Supplemental Scheduling Order Issued In Amgen v. Apotex

Amgen v. Apotex (pegfilgrastim)  •  Biosimilar News  •  BPCIA and Related U.S. Statutes  •  U.S. Biosimilar Litigation News

Yesterday Judge Cohn issued a supplemental scheduling order in Amgen v. Apotex.  The hearing for Amgen’s Motion for Preliminary Injunction has been rescheduled for December 3, 2015.  Claim construction briefing will occur in December and January, and the claim construction hearing will be held on February 5, 2016.  Expert reports are to follow in March and April, 2016.

The Supplemental Scheduling Order is available here.

Download PDF

Tagged with 

Comments are closed.